Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-12

Clinical Trial Update: HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing haloperidol versus olanzapine for hyperactive delirium in palliative care patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • olanzapine (olanzapine)

Snippet

Sponsor: Tan Tock Seng Hospital | Conditions: Haloperidol, Advanced Cancer | Phase 3 | Status: RECRUITING